title: CYP2C19 in ACS Patients: Could Genotyping Have a Role in Medically Managed Patients or Beyond?
authors.affiliation: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany; DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. Electronic address: dirk@sibbing.net.
authors.forename: Dirk
authors.initials: D
authors.lastname: Sibbing
authors.affiliation: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany; DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
authors.forename: Lisa
authors.initials: L
authors.lastname: Gross
authors.affiliation: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany; DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
authors.forename: Steffen
authors.initials: S
authors.lastname: Massberg
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D065731:Cytochrome P-450 CYP2C19 / Q000235:genetics*; D004247:DNA / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D011110:Polymorphism, Genetic; D000068799:Prasugrel Hydrochloride / Q000008:administration & dosage*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D004247:DNA; D065731:Cytochrome P-450 CYP2C19; D000068799:Prasugrel Hydrochloride; D013988:Ticlopidine
keywords: acute coronary syndrome; dual antiplatelet therapy; genetics; platelets